CureVac NV Financials
| 5CV Stock | EUR 2.72 0.04 1.45% |
CureVac |
Understanding current and past CureVac NV Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CureVac NV's financial statements are interrelated, with each one affecting the others. For example, an increase in CureVac NV's assets may result in an increase in income on the income statement.
CureVac NV Stock Summary
CureVac NV competes with Superior Plus, NMI Holdings, Origin Agritech, SIVERS SEMICONDUCTORS, and NorAm Drilling. CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid . The company was founded in 2000 and is headquartered in Tbingen, Germany. CUREVAC N operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 455 people.| Foreign Associate | Germany |
| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | NL0015436031 |
| Business Address | Friedrich-Miescher-Strasse 15, Tbingen, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.curevac.com |
| Phone | 49 7071 9883 0 |
| Currency | EUR - Euro |
You should never invest in CureVac NV without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of CureVac Stock, because this is throwing your money away. Analyzing the key information contained in CureVac NV's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
CureVac NV Key Financial Ratios
There are many critical financial ratios that CureVac NV's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CureVac NV reports annually and quarterly.| Return On Equity | -0.19 | |||
| Return On Asset | -0.34 | |||
| Target Price | 72.97 | |||
| Number Of Employees | 764 | |||
| Beta | 2.93 |
CureVac Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CureVac NV's current stock value. Our valuation model uses many indicators to compare CureVac NV value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CureVac NV competition to find correlations between indicators driving CureVac NV's intrinsic value. More Info.CureVac NV is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CureVac NV's earnings, one of the primary drivers of an investment's value.CureVac NV Systematic Risk
CureVac NV's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CureVac NV volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on CureVac NV correlated with the market. If Beta is less than 0 CureVac NV generally moves in the opposite direction as compared to the market. If CureVac NV Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CureVac NV is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CureVac NV is generally in the same direction as the market. If Beta > 1 CureVac NV moves generally in the same direction as, but more than the movement of the benchmark.
CureVac NV December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CureVac NV help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CureVac NV. We use our internally-developed statistical techniques to arrive at the intrinsic value of CureVac NV based on widely used predictive technical indicators. In general, we focus on analyzing CureVac Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CureVac NV's daily price indicators and compare them against related drivers.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 15.82 | |||
| Value At Risk | (4.97) | |||
| Potential Upside | 6.32 |
Complementary Tools for CureVac Stock analysis
When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |